Proton beam radiation or external beam radiation or brachytherapy + Surgical Resection + DACTINOMYCIN + Vincristine + Cyclophosphamide for rhabdomyosarcoma
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
5 Sep 2023: Trial registered, NCT06023641
13 Mar 2024: Trial started, NCT06023641
The trials
NCT06023641: Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
State
Under way
Phase
Phase 2
People
135 planned
Started
13 Mar 2024
Primary completion
Oct 2034
Arms
Low -risk
Results
None posted
5 Sep 2023: Trial registered
13 Mar 2024: Trial started
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.